Molecular Basis of beta-Thalassemia in the Population of the Aegean Region of Turkey: Identification of A Novel Deletion Mutation
dc.contributor.author | Özkınay, Ferda | |
dc.contributor.author | Onay, Huseyin | |
dc.contributor.author | Karaca, Emin | |
dc.contributor.author | Arslan, Esra | |
dc.contributor.author | Erturk, Biray | |
dc.contributor.author | Solmaz, Asli Ece | |
dc.contributor.author | Tekin, Ismihan Merve | |
dc.contributor.author | Cogulu, Ozgur | |
dc.contributor.author | Aydinok, Yesim | |
dc.contributor.author | Vergin, Canan | |
dc.date.accessioned | 2019-10-27T22:29:20Z | |
dc.date.available | 2019-10-27T22:29:20Z | |
dc.date.issued | 2015 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | beta-Thalassemia (beta-thal) is the most common monogenic disorder in Turkey. The aim of this study was to investigate the spectrum of beta-thal mutations in the Aegean region of Turkey. The data was derived from 1171 unrelated beta-thal subjects, detected in a regional reference hospital between November 2004 and December 2013. Screening for the 22 common mutations was performed using the polymerase chain reaction (PCR)-reverse dot-blot method, and direct automated DNA sequencing for the unknown samples. Thirty-one different beta-thal alleles were identified. Seven mutations, namely IVS-I-110 (G>A) (41.7%), IVS-I-1 (G>A) (8.9%), IVS-II-745 (C>G) (8.6%), codon 8 (-AA) (7.7%), IVS-II-1 (G>A) (7.2%), IVS-I-6 (T>C) (6.6%), codon 39 (C>T) (4.6%) accounted for 85.3% of the mutated alleles. Frequencies of the remaining 24 beta-thal mutations were less than 2.2%; these included one novel mutation [HBB: c. 206_ 212del (p. Leu69Profs* 19)], and four others [-56 (G>C), codon 16 (-C), IVS-I (-3) (C>T) (codon 29), codon 76 (-C)] found in Turkey for the first time. The results will help to prevent severe beta-thal through genetic counseling and prenatal diagnosis (PND) in the Aegean region of Turkey. | en_US |
dc.identifier.doi | 10.3109/03630269.2015.1038354 | en_US |
dc.identifier.endpage | 234 | en_US |
dc.identifier.issn | 0363-0269 | |
dc.identifier.issn | 1532-432X | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 26076395 | en_US |
dc.identifier.startpage | 230 | en_US |
dc.identifier.uri | https://doi.org/10.3109/03630269.2015.1038354 | |
dc.identifier.uri | https://hdl.handle.net/11454/51085 | |
dc.identifier.volume | 39 | en_US |
dc.identifier.wos | WOS:000361322400003 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Hemoglobin | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | beta-Thalassemia (beta-thal) | en_US |
dc.subject | beta-globin gene | en_US |
dc.subject | mutation spectrum | en_US |
dc.subject | thalassemias | en_US |
dc.title | Molecular Basis of beta-Thalassemia in the Population of the Aegean Region of Turkey: Identification of A Novel Deletion Mutation | en_US |
dc.type | Article | en_US |